IperionX Limited logo IPX - IperionX Limited

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $46.50 DETAILS
HIGH: $53.00
LOW: $40.00
MEDIAN: $46.50
CONSENSUS: $46.50
UPSIDE: 79.88%

Stock News

IperionX Announces Pricing of Public Offering of American Depositary Shares

IperionX Announces Pricing of Public Offering of American Depositary Shares

SOUTH BOSTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (“IperionX” or the “Company”) (Nasdaq:IPX; ASX:IPX) today announced the pricing of an underwritten public offering of 2,275,000 of its American Depositary Shares (“ADSs”), with each ADS representing 10 of its ordinary shares (“Public Offering”), at a price per ADS to the public of $21.98, for aggregate gross proceeds of approximately $50 million, before deducting underwriting discounts, commission and estimated offering expenses payable by the Company.

Jul 07, 2026 03:51 PM globenewswire.com
IperionX Completes Strategic Camden Acquisition - Unlocking Ultra-High-Grade Critical Minerals to Accelerate U.S. Supply Chain

IperionX Completes Strategic Camden Acquisition - Unlocking Ultra-High-Grade Critical Minerals to Accelerate U.S. Supply Chain

INVESTMENT HIGHLIGHTS Transformational asset integration & strategic scale: IperionX has successfully completed the acquisition of the Camden critical mineral, heavy rare earths, and infrastructure assets. Highly synergistic with the adjacent Titan Project in Tennessee, this acquisition materially consolidates and expands IperionX's landholding across the Big Sandy Critical Minerals Province.

Jul 02, 2026 04:30 AM globenewswire.com
IperionX Awarded Up to US$6.6M by OSW-SWIB to Scale U.S. Titanium Plate for Defense Applications

IperionX Awarded Up to US$6.6M by OSW-SWIB to Scale U.S. Titanium Plate for Defense Applications

IperionX awarded up to US$6.6 million by the Office of the Secretary of War – Submarine Workforce and Industrial Base program (OSW-SWIB) The award forms part of a larger, multi-organization program to scale production of high-performance titanium alloy products, including ballistic-grade titanium plate, for land and maritime defense platforms Funding will support expanded manufacturing capability for large-format military titanium components at IperionX's Titanium Manufacturing Campus in Virginia, strengthening U.S. capacity for mission-critical titanium products and critical-material supply chains IperionX will collaborate with the George H. W. Bush Combat Development Complex (BCDC) and the U.S. Army Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL) to accelerate product scale-up, validation, and transition pathways for defense and strategic industrial applications Alongside the OSW-SWIB award, IperionX has received an additional purchase order from the U.S. Army Ground Vehicle Systems Center to manufacture a range of titanium fasteners for the JLTV in support of U.S. Army and Marine Corps operational requirements SOUTH BOSTON, Va.

Jul 01, 2026 04:30 AM globenewswire.com
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations

Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations

MILAN and BRIDGEWATER, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Zambon and Amneal Pharmaceuticals today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European Medicines Agency (EMA) for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson's disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/DDC inhibitor-based treatment regimens.

Jun 28, 2026 11:00 PM globenewswire.com
IperionX Commissions Six-Axis Powder Metallurgy Press, Expanding U.S. Titanium Component Manufacturing Capabilities

IperionX Commissions Six-Axis Powder Metallurgy Press, Expanding U.S. Titanium Component Manufacturing Capabilities

Commissioned advanced 300-ton, six-axis SACMI powder metallurgy press at IperionX's Titanium Manufacturing Campus in South Boston, Virginia Triples IperionX's existing powder metallurgy capacity and materially expands the range of high-value titanium powder-to-product components that can be manufactured in the United States Significantly enhances product flexibility and production repeatability, enabling more complex near-net-shape titanium components including fasteners, gears, brackets, actuators and other high-value defense, aerospace and industrial parts High-productivity titanium manufacturing platform capable of up to 24 pressing cycles per minute, equivalent to approximately 11 million single-cavity parts per year under operating assumptions, with higher part rates achievable using multi-cavity tooling for simpler components Designed to integrate with additional HSPT™ furnace capacity expected to arrive in June, supporting customer qualification, low-rate initial production and the scale-up of titanium component manufacturing in Virginia SOUTH BOSTON, Va., May 21, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to announce the successful completion of site acceptance and commissioning of its advanced 300-ton six-axis SACMI powder metallurgy press at IperionX's Titanium Manufacturing Campus in South Boston, Virginia.

May 21, 2026 04:30 AM globenewswire.com
IPX1031 Expands Midwest Presence with Scott Schofield

IPX1031 Expands Midwest Presence with Scott Schofield

DETROIT, May 13, 2026 (GLOBE NEWSWIRE) -- Investment Property Exchange Services, Inc. (IPX1031), the national leader in 1031 Exchange services, announces the expansion of its Midwest presence with Scott Schofield supporting clients throughout Michigan, Minnesota, Iowa, North Dakota, and South Dakota alongside Vice President TC Fair. This expansion reflects IPX1031's continued investment in providing local market expertise and personalized service to investors, advisors, and real estate professionals throughout the Midwest.

May 13, 2026 07:31 AM globenewswire.com
IperionX Investor Update: Ramps U.S. Titanium Scale-Up as Demand Soars, Titan Project Update Nears

IperionX Investor Update: Ramps U.S. Titanium Scale-Up as Demand Soars, Titan Project Update Nears

IperionX (NASDAQ: IPX) said it is accelerating the scale-up of its U.S.-based titanium metal supply chain as it seeks to address what it described as record demand, long lead times, and rising geopolitical risk in global titanium markets. In a company presentation, the speaker pointed to heightened U.S. defense spending, government reshoring initiatives, and emerging industrial

Apr 29, 2026 10:20 AM defenseworld.net
IperionX Limited Sponsored ADR (NASDAQ:IPX) Receives $55.33 Consensus Price Target from Analysts

IperionX Limited Sponsored ADR (NASDAQ:IPX) Receives $55.33 Consensus Price Target from Analysts

IperionX Limited Sponsored ADR (NASDAQ: IPX - Get Free Report) has received an average recommendation of "Moderate Buy" from the five brokerages that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation and four have assigned a buy recommendation to the company. The average twelve-month price target among brokerages

Mar 29, 2026 11:17 PM defenseworld.net
Securities Fraud Investigation Into IperionX Limited (IPX) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Securities Fraud Investigation Into IperionX Limited (IPX) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of IperionX Limited (“IperionX” or the “Company”) (NASDAQ: IPX) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON IPERIONX LIMITED (IPX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On March 13, 2026, IperionX disclos.

Mar 19, 2026 06:00 AM businesswire.com (Hide legal announcements)
Securities Fraud Investigation Into IperionX Limited (IPX) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Securities Fraud Investigation Into IperionX Limited (IPX) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of IperionX Limited (“IperionX” or the “Company”) (NASDAQ: IPX) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON IPERIONX LIMITED (IPX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 13, 2026, IperionX disclosed that its financial report for the.

Mar 18, 2026 12:20 PM businesswire.com (Hide legal announcements)
Securities Fraud Investigation Into IperionX Limited (IPX) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Securities Fraud Investigation Into IperionX Limited (IPX) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of IperionX Limited (“IperionX” or the “Company”) (NASDAQ: IPX) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON IPERIONX LIMITED (IPX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On March 13, 2026, IperionX disclos.

Mar 18, 2026 12:00 PM businesswire.com (Hide legal announcements)

Price Targets